Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from ASKA Pharmaceutical Holdings Co., Ltd. ( (JP:4886) ) is now available.
ASKA Pharmaceutical Holdings Co., Ltd. has been recognized as a White 500 enterprise for the seventh consecutive year, highlighting its commitment to health and productivity management. The company has implemented various initiatives such as thyroid function tests, preconception care seminars, and a Work Support Bonus to enhance employee health and work-life balance, reinforcing its position as a leader in the healthcare industry.
More about ASKA Pharmaceutical Holdings Co., Ltd.
ASKA Pharmaceutical Holdings Co., Ltd. is a healthcare company based in Tokyo, Japan. It focuses on developing innovative products in the areas of prevention, testing/diagnosis, treatment, and prognosis, aiming to improve people’s health and societal progress.
YTD Price Performance: 4.81%
Average Trading Volume: 52,264
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: Yen62.51B
Learn more about 4886 stock on TipRanks’ Stock Analysis page.